Financial Snapshot

Revenue
$13.55M
TTM
Gross Margin
38.7%
TTM
Net Earnings
-$3.686M
TTM
Current Assets
Q3 2024
Current Liabilities
Q3 2024
Current Ratio
369.33%
Q3 2024
Total Assets
Q3 2024
Total Liabilities
Q3 2024
Book Value
$5.352M
Q3 2024
Cash
Q3 2024
P/E
-0.9773
Nov 29, 2024 EST
Free Cash Flow
-$1.534M
TTM

Revenues

Revenues

Loading...

Revenue YoY Change

Loading...

Revenues

Concept 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003
Revenue $12.74M $13.27M $12.63M $18.63M $18.94M $18.97M $16.66M $12.83M $9.370M $13.85M $13.67M $15.45M $12.74M $9.750M $7.360M $5.390M $3.840M $4.540M $2.580M $1.360M $900.0K $2.470M
YoY Change -4.05% 5.1% -32.21% -1.64% -0.16% 13.87% 29.85% 36.93% -32.35% 1.32% -11.52% 21.27% 30.67% 32.47% 36.55% 40.36% -15.42% 75.97% 89.71% 51.11% -63.56% 23.5%

Expenses

Cost Of Revenues

Loading...

Gross Profit

Loading...

Gross Profit Margin

Loading...

Gross Profit

Concept 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003
Revenue $12.74M $13.27M $12.63M $18.63M $18.94M $18.97M $16.66M $12.83M $9.370M $13.85M $13.67M $15.45M $12.74M $9.750M $7.360M $5.390M $3.840M $4.540M $2.580M $1.360M $900.0K $2.470M
Cost Of Revenue $7.990M $8.795M $8.417M $11.85M $10.60M $10.09M $9.350M $7.160M $6.720M $6.570M $5.270M $4.710M $4.030M $3.610M $3.490M $2.590M $2.750M $3.000M $4.900M $3.520M $2.670M $1.770M
Gross Profit $4.745M $4.477M $4.211M $6.782M $8.330M $8.880M $7.310M $5.670M $2.650M $7.290M $8.400M $10.74M $8.710M $6.140M $3.880M $2.800M $1.080M $1.540M -$2.320M -$2.170M -$1.770M $700.0K
Gross Profit Margin 37.26% 33.73% 33.35% 36.41% 43.98% 46.81% 43.88% 44.19% 28.28% 52.64% 61.45% 69.51% 68.37% 62.97% 52.72% 51.95% 28.13% 33.92% -89.92% -159.56% -196.67% 28.34%

Selling, General & Admin Expense

Loading...

Research & Development

Loading...

Depreciation, Depletion & Amortization

Loading...

SGA Expense to Gross Profit Ratio

Loading...

R&D To Gross Profit Ratio

Loading...

DDA To Gross Profit Ratio

Loading...

Operating Expenses Total

Loading...

Operating Profits/Loss

Loading...

Operational Expenses

Concept 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003
Selling, General & Admin $7.575M $8.840M $9.755M $9.453M $13.67M $18.62M $19.92M $17.07M $15.56M $12.41M $11.56M $11.89M $13.20M $11.60M $9.900M $13.86M $13.73M $16.52M $15.93M $12.49M $3.920M $2.100M
YoY Change -14.31% -9.38% 3.19% -30.85% -26.58% -6.53% 16.7% 9.7% 25.38% 7.35% -2.78% -9.92% 13.79% 17.17% -28.57% 0.95% -16.89% 3.7% 27.54% 218.62% 86.67% 57.89%
% of Gross Profit 159.64% 197.45% 231.66% 139.38% 164.11% 209.68% 272.5% 301.06% 587.17% 170.23% 137.62% 110.71% 151.55% 188.93% 255.15% 495.0% 1271.3% 1072.73% 300.0%
Research & Development $1.871M $207.0K $125.0K $555.0K $1.340M $1.520M $1.580M $1.580M $1.810M $1.530M $2.890M $2.220M $1.980M $2.050M $2.000M $6.250M $9.780M $4.510M $2.600M $1.650M $1.410M $70.00K
YoY Change 803.86% 65.6% -77.48% -58.58% -11.84% -3.8% 0.0% -12.71% 18.3% -47.06% 30.18% 12.12% -3.41% 2.5% -68.0% -36.09% 116.85% 73.46% 57.58% 17.02% 1914.29% 600.0%
% of Gross Profit 39.43% 4.62% 2.97% 8.18% 16.09% 17.12% 21.61% 27.87% 68.3% 20.99% 34.4% 20.67% 22.73% 33.39% 51.55% 223.21% 905.56% 292.86% 10.0%
Depreciation & Amortization $176.0K $125.0K $186.0K $227.0K $310.0K $450.0K $490.0K $250.0K $240.0K $250.0K $280.0K $270.0K $330.0K $400.0K $430.0K $770.0K $740.0K $670.0K $650.0K $430.0K $160.0K
YoY Change 40.8% -32.8% -18.06% -26.77% -31.11% -8.16% 96.0% 4.17% -4.0% -10.71% 3.7% -18.18% -17.5% -6.98% -44.16% 4.05% 10.45% 3.08% 51.16% 168.75%
% of Gross Profit 3.71% 2.79% 4.42% 3.35% 3.72% 5.07% 6.7% 4.41% 9.06% 3.43% 3.33% 2.51% 3.79% 6.51% 11.08% 27.5% 68.52% 43.51%
Operating Expenses $9.446M $9.047M $9.880M $10.01M $15.01M $20.14M $21.50M $18.64M $17.36M $13.94M $14.45M $14.12M $15.18M $13.65M $11.89M $20.11M $23.51M $21.03M $18.54M $14.15M $5.330M $2.170M
YoY Change 4.41% -8.43% -1.28% -33.32% -25.47% -6.33% 15.34% 7.37% 24.53% -3.53% 2.34% -6.98% 11.21% 14.8% -40.88% -14.46% 11.79% 13.43% 31.02% 165.48% 145.62% 63.16%
Operating Profit -$4.701M -$4.570M -$5.669M -$3.226M -$6.680M -$11.26M -$14.19M -$12.97M -$14.71M -$6.650M -$6.050M -$3.380M -$6.470M -$7.510M -$8.010M -$17.31M -$22.43M -$19.49M -$20.86M -$16.32M -$7.100M -$1.470M
YoY Change 2.87% -19.39% 75.73% -51.71% -40.67% -20.65% 9.41% -11.83% 121.2% 9.92% 78.99% -47.76% -13.85% -6.24% -53.73% -22.83% 15.08% -6.57% 27.82% 129.86% 382.99% 950.0%

Interest Expenses

Loading...

Interest Expenses To Operating Income %

Loading...

Other Expense/Income

Loading...

Interest & Other Expense/Income

Concept 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003
Interest Expense -$825.0K $16.00K -$10.00K $4.000K $30.00K $160.0K $220.0K $20.00K $10.00K $3.160M $9.870M -$1.930M -$650.0K -$270.0K -$160.0K -$290.0K -$390.0K -$640.0K $110.0K -$360.0K -$180.0K -$120.0K
YoY Change -5256.25% -260.0% -350.0% -86.67% -81.25% -27.27% 1000.0% 100.0% -99.68% -67.98% -611.4% 196.92% 140.74% 68.75% -44.83% -25.64% -39.06% -681.82% -130.56% 100.0% 50.0% 500.0%
% of Operating Profit
Other Income/Expense, Net $495.0K -$631.0K -$394.0K -$594.0K $240.0K -$240.0K -$310.0K $20.00K -$20.00K -$60.00K -$80.00K -$130.0K -$220.0K -$180.0K -$60.00K -$60.00K $2.470M $350.0K -$380.0K $150.0K -$30.00K $0.00
YoY Change -178.45% 60.15% -33.67% -347.5% -200.0% -22.58% -1650.0% -200.0% -66.67% -25.0% -38.46% -40.91% 22.22% 200.0% 0.0% -102.43% 605.71% -192.11% -353.33% -600.0%

Income/Loss

Pretax Income

Loading...

Income Tax

Loading...

Net Profits/Loss

Loading...

Pretax Income YoY Change

Loading...

Income Tax Rate

Loading...

Net Profits/Loss YoY Change

Loading...

Basic EPS

Loading...

Net Income To Revenue Ratio

Loading...

Pretax & Net Income

Concept 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003
Pretax Income -$5.031M -$5.184M -$5.418M -$3.902M -$2.830M -$11.34M -$14.28M -$12.94M -$14.72M -$8.200M $3.740M -$5.430M -$7.330M -$7.950M -$8.230M -$17.66M -$20.34M -$19.78M -$21.12M -$16.53M -$7.300M -$1.600M
YoY Change -2.95% -4.32% 38.85% 37.88% -75.04% -20.59% 10.36% -12.12% 79.56% -319.25% -168.88% -25.92% -7.8% -3.4% -53.4% -13.18% 2.83% -6.34% 27.77% 126.44% 356.25% 841.18%
Income Tax -$196.0K -$33.00K -$332.0K $713.0K $120.0K $460.0K $50.00K -$4.270M $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
% Of Pretax Income 0.0%
Net Earnings -$4.835M -$5.151M -$5.086M -$3.950M -$2.950M -$11.80M -$14.33M $9.270M -$10.16M -$8.200M $3.740M -$5.430M -$7.330M -$7.950M -$8.230M -$17.66M -$20.34M -$19.78M -$23.10M -$16.53M -$7.300M -$1.600M
YoY Change -6.13% 1.28% 28.76% 33.9% -75.0% -17.66% -254.58% -191.24% 23.9% -319.25% -168.88% -25.92% -7.8% -3.4% -53.4% -13.18% 2.83% -14.37% 39.75% 126.44% 356.25% 841.18%
Net Earnings / Revenue -37.97% -38.81% -40.28% -21.2% -15.58% -62.2% -86.01% 72.25% -108.43% -59.21% 27.36% -35.15% -57.54% -81.54% -111.82% -327.64% -529.69% -435.68% -895.35% -1215.44% -811.11% -64.78%
Basic Earnings Per Share -$0.53 -$1.52 -$1.92
Diluted Earnings Per Share -$0.53 -$1.52 -$1.917M -$1.979M -$1.993M -$12.83M -$28.66M $19.72M -$27.46M -$39.05M $24.93M -$49.36M -$81.44M -$99.38M -$117.6M -$353.2M -$508.5M -$989.0M -$2.310B -$413.3M -$182.5M -$40.00M

Assets & Liabilities

Cash & Short-Term Investments

Loading...

Cash & Equivalents

Loading...

Cash To Operating Expenses Ratio

Loading...

Inventory

Loading...

Receivables

Loading...

Total Short-Term Assets

Loading...

Property, Plant And Equipment

Loading...

Long-Term Investments

Loading...

Total Long-Term Assets

Loading...

Total Assets

Loading...

Net Income To Total Assets Percentage

Loading...

Accounts Payable

Loading...

Short-Term Debt

Loading...

Long Term Debt Due

Loading...

Total Short-Term Liabilities

Loading...

Long-Term Debt

Loading...

Other Long-Term Liabilities

Loading...

Total Long-Term Liabilities

Loading...

Total Liabilities

Loading...

Short-Term To Long-Term Debt Ratio

Loading...

Short-Term Assets To Debt Ratio

Loading...

Long-Term Debt To Net Income Ratio

Loading...

Assets & Liabilities

Concept 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003
Cash & Short-Term Investments $3.128M $3.820M $7.396M $4.220M $3.690M $3.690M $10.07M $17.46M $7.470M $6.140M $5.480M $7.900M $3.350M $4.370M $6.260M $1.920M $18.82M $19.05M $7.450M $3.290M
YoY Change -18.12% -48.35% 75.26% 14.36% 0.0% -63.36% -42.33% 133.73% 21.66% 12.04% -30.63% 135.82% -23.34% -30.19% 226.04% -89.8% -1.21% 155.7% 126.44%
Cash & Equivalents $3.128M $3.820M $7.396M $4.220M $3.690M $3.690M $10.07M $17.46M $7.470M $6.140M $5.480M $7.900M $3.350M $4.370M $6.260M $1.920M $18.82M $19.05M $7.450M $3.290M
Short-Term Investments
Other Short-Term Assets $707.0K $703.0K $1.593M $1.577M $1.130M $950.0K $1.570M $860.0K $2.320M $590.0K $650.0K $930.0K $500.0K $580.0K $780.0K $740.0K $1.070M $3.050M $660.0K $500.0K
YoY Change 0.57% -55.87% 1.01% 39.56% 18.95% -39.49% 82.56% -62.93% 293.22% -9.23% -30.11% 86.0% -13.79% -25.64% 5.41% -30.84% -64.92% 362.12% 32.0%
Inventory $2.719M $2.858M $2.663M $2.530M $2.190M $3.410M $2.870M $2.220M $1.600M $1.400M $1.090M $990.0K $950.0K $730.0K $570.0K $340.0K $260.0K $280.0K $320.0K $870.0K
Prepaid Expenses
Receivables $2.898M $2.572M $2.407M $2.806M $4.060M $3.480M $1.540M $2.110M $1.510M $1.520M $1.790M $1.710M $2.150M $2.090M $1.420M $920.0K $770.0K $1.360M $1.080M $230.0K
Other Receivables $3.096M $3.845M $2.371M $1.850M $1.310M $960.0K $210.0K $0.00 $0.00 $0.00 $540.0K $0.00 $10.00K $30.00K $30.00K $30.00K $30.00K $130.0K $720.0K $0.00
Total Short-Term Assets $12.55M $13.80M $16.43M $12.98M $12.38M $12.50M $16.25M $22.64M $12.89M $9.650M $9.540M $11.53M $6.960M $7.810M $9.050M $3.940M $20.95M $23.87M $10.23M $4.880M
YoY Change -9.06% -16.02% 26.55% 4.87% -0.96% -23.08% -28.22% 75.64% 33.58% 1.15% -17.26% 65.66% -10.88% -13.7% 129.7% -81.19% -12.23% 133.33% 109.63%
Property, Plant & Equipment $651.0K $906.0K $879.0K $1.129M $1.330M $730.0K $1.140M $1.240M $850.0K $800.0K $970.0K $800.0K $810.0K $800.0K $1.110M $1.430M $2.300M $2.210M $1.940M $1.960M
YoY Change -28.15% 3.07% -22.14% -15.11% 82.19% -35.96% -8.06% 45.88% 6.25% -17.53% 21.25% -1.23% 1.25% -27.93% -22.38% -37.83% 4.07% 13.92% -1.02%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $4.540M $10.15M
YoY Change -55.27%
Other Assets $1.541M $1.527M $1.536M $875.0K $850.0K $1.230M $1.820M $1.580M $70.00K $70.00K $130.0K $230.0K $70.00K $50.00K $60.00K $70.00K $360.0K $880.0K $520.0K $50.00K
YoY Change 0.92% -0.59% 75.54% 2.94% -30.89% -32.42% 15.19% 2157.14% 0.0% -46.15% -43.48% 228.57% 40.0% -16.67% -14.29% -80.56% -59.09% 69.23% 940.0%
Total Long-Term Assets $2.192M $2.433M $2.415M $2.004M $2.180M $1.950M $2.960M $2.820M $910.0K $5.400M $11.25M $1.040M $880.0K $850.0K $1.170M $1.510M $2.660M $3.080M $2.460M $2.060M
YoY Change -9.91% 0.75% 20.51% -8.07% 11.79% -34.12% 4.96% 209.89% -83.15% -52.0% 981.73% 18.18% 3.53% -27.35% -22.52% -43.23% -13.64% 25.2% 19.42%
Total Assets $14.74M $16.23M $18.85M $14.99M $14.56M $14.45M $19.21M $25.46M $13.80M $15.05M $20.79M $12.57M $7.840M $8.660M $10.22M $5.450M $23.61M $26.95M $12.69M $6.940M
YoY Change
Accounts Payable $607.0K $841.0K $1.641M $1.769M $2.090M $1.260M $1.270M $1.260M $1.340M $930.0K $740.0K $810.0K $820.0K $670.0K $980.0K $1.570M $2.980M $2.550M $2.770M $910.0K
YoY Change -27.82% -48.75% -7.24% -15.36% 65.87% -0.79% 0.79% -5.97% 44.09% 25.68% -8.64% -1.22% 22.39% -31.63% -37.58% -47.32% 16.86% -7.94% 204.4%
Accrued Expenses $1.617M $1.719M $1.309M $1.027M $1.560M $1.240M $1.020M -$540.7M $1.530M $650.0K $530.0K $600.0K $820.0K $650.0K $760.0K $580.0K $2.100M $1.370M $1.530M $2.340M
YoY Change -5.93% 31.32% 27.46% -34.17% 25.81% 21.57% -100.19% -35439.87% 135.38% 22.64% -11.67% -26.83% 26.15% -14.47% 31.03% -72.38% 53.28% -10.46% -34.62%
Deferred Revenue
YoY Change
Short-Term Debt $323.0K $431.0K $688.0K $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
YoY Change -25.06% -37.35%
Long-Term Debt Due $0.00 $120.0K $596.0K $480.0K $460.0K $380.0K $200.0K $110.0K $90.00K $140.0K $1.300M $1.420M $910.0K $200.0K $260.0K $2.010M $6.060M $520.0K $980.0K
YoY Change -100.0% -79.87% 24.17% 4.35% 21.05% 90.0% 81.82% 22.22% -35.71% -89.23% -8.45% 56.04% 355.0% -23.08% -87.06% -66.83% 1065.38% -46.94%
Total Short-Term Liabilities $3.719M $3.717M $5.819M $4.078M $4.870M $3.590M $3.260M $3.290M $3.550M $2.580M $7.570M $5.130M $4.750M $4.420M $2.740M $2.680M $7.450M $10.03M $5.100M $4.220M
YoY Change 0.05% -36.12% 42.69% -16.26% 35.65% 10.12% -0.91% -7.32% 37.6% -65.92% 47.56% 8.0% 7.47% 61.31% 2.24% -64.03% -25.72% 96.67% 20.85%
Long-Term Debt $0.00 $0.00 $0.00 $1.310M $0.00 $10.00K $180.0K $210.0K $0.00 $0.00 $0.00 $740.0K $1.820M $1.640M $110.0K $70.00K $210.0K $2.020M $250.0K $520.0K
YoY Change -100.0% -100.0% -94.44% -14.29% -100.0% -59.34% 10.98% 1390.91% 57.14% -66.67% -89.6% 708.0% -51.92%
Other Long-Term Liabilities $4.884M $4.537M $4.329M $4.236M $990.0K $360.0K $440.0K $530.0K $110.0K $410.0K $1.150M $2.620M $2.130M $910.0K $330.0K $430.0K $520.0K $0.00
YoY Change 7.65% 4.8% 2.2% 327.88% 175.0% -18.18% -16.98% 381.82% -73.17% -64.35% -56.11% 23.0% 134.07% 175.76% -23.26% -17.31%
Total Long-Term Liabilities $4.884M $4.537M $4.329M $5.546M $990.0K $370.0K $620.0K $740.0K $110.0K $410.0K $1.150M $3.360M $3.950M $2.550M $440.0K $500.0K $730.0K $2.020M $250.0K $520.0K
YoY Change 7.65% 4.8% -21.94% 460.2% 167.57% -40.32% -16.22% 572.73% -73.17% -64.35% -65.77% -14.94% 54.9% 479.55% -12.0% -31.51% -63.86% 708.0% -51.92%
Total Liabilities $8.603M $8.254M $10.15M $9.624M $5.860M $3.960M $3.880M $4.030M $3.660M $2.990M $8.730M $8.480M $8.710M $6.960M $3.170M $3.180M $8.180M $12.05M $5.350M $4.740M
YoY Change 4.23% -18.66% 5.44% 64.23% 47.98% 2.06% -3.72% 10.11% 22.41% -65.75% 2.95% -2.64% 25.14% 119.56% -0.31% -61.12% -32.12% 125.23% 12.87%

Ownership

Basic Shares Outstanding

Loading...

Diluted Shares Outstanding

Loading...

Preferred Stock

Loading...

Treasury Stock Shares

Loading...

Stock Issuance & Repurchase

Loading...

Ownership Data

Concept 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003
Basic Shares Outstanding 9.090M shares 3.394K shares 2.653K shares
Diluted Shares Outstanding 9.090M shares 3.394K shares 2.653K shares
Preferred Stock
Treasury Stock Shares

Return On Shareholders' Equity

Loading...

Book Value

Loading...

Free Cash Flow

Loading...

Free Cash Flow YoY

Loading...

Free Cash Flow Margin

Loading...

Dividends

Dividends

Loading...

Stock Price

Loading...
Market Cap: $3.6024 Million

About Sonoma Pharmaceuticals, Inc.

Sonoma Pharmaceuticals Inc is a US-based company operating in Pharmaceuticals industry. The company is headquartered in Boulder, Colorado and currently employs 172 full-time employees. The company went IPO on 2007-01-26. Sonoma Pharmaceuticals, Inc. is a global healthcare company, which is engaged in developing and producing stabilized hypochlorous acid (HOCl), products for a range of applications, including wound care, eye care, oral care, dermatological conditions, podiatry, animal health care and non-toxic disinfectants. The firm's product offerings include Lumacyn Clarifying Mist; Regenacyn Advanced Scar Gel; Reliefacyn Advanced Itch-Burn-Rash-Pain Relief Hydrogel; Microcyn OTC Advanced Wound & Skin Cleanser; Podiacyn Advanced Everyday Foot Care, MicrocynAH and others. Lumacyn Clarifying Mist is intended for use as a daily skin toner, to soothe and cleanse the skin, reduce redness, and manage blemishes by reducing infection. Podiacyn is intended for management of foot odors, infections, and irritations, as well as daily foot health and hygiene. MicrocynAH is an HOCl-based topical product that cleans, debrides and treats a range of animal wounds and infections.

Industry: Surgical & Medical Instruments & Apparatus Peers: Enveric Biosciences, Inc. Can B Corp Evoke Pharma Inc KIORA PHARMACEUTICALS INC Grapefruit USA, Inc GREEN HYGIENICS HOLDINGS INC. JOHNSON & JOHNSON One World Products, Inc. NovaBay Pharmaceuticals, Inc. Stem Holdings, Inc.